Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.
about
Breast dynamic contrast-enhanced examinations with fat suppression: are contrast-agent uptake curves affected by magnetic field inhomogeneity?Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis.Quality assurance in MRI breast screening: comparing signal-to-noise ratio in dynamic contrast-enhanced imaging protocols.3.0T MR-CAD: Clinical Value in Diagnosis of Breast Tumor Compared with Conventional MRIComputerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.Investigating the influence of flip angle and k-space sampling on dynamic contrast-enhanced MRI breast examinationsA prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation.The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.Development and characterization of a dynamic lesion phantom for the quantitative evaluation of dynamic contrast-enhanced MRIDiscrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions?Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor ModelComparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0 T: a pilot study.Spectral characterization of tissues in high spectral and spatial resolution MR images: Implications for a classification-based synthetic CT algorithm.A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settingsMRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancersEvaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.Effect of protocol parameters on contrast agent washout curve separability in breast dynamic contrast enhanced MRI: a simulation study.Quantitative evaluation of contrast agent uptake in standard fat-suppressed dynamic contrast-enhanced MRI examinations of the breast.Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.Effects of MRI scanner parameters on breast cancer radiomics
P2860
Q30581763-F86759EE-8FB8-4AFF-8F22-5AD2D27E8BD8Q30896010-28BCA9B3-1985-499A-91AF-6A5F684BDB40Q33562510-A25ABFD7-3BDF-48B2-8FD3-6332C1641074Q33935230-23118591-8B8D-43D8-AA8C-50E7F432CEFAQ34010957-6379DD15-85E1-4D3D-9BF1-423F56037A3EQ34199850-A19E2A11-BC4E-4EA3-B0FB-2C1810475F86Q34522677-3DFF495F-8F2B-4EF4-AF83-7F04F2C34A03Q34794940-E172A447-9ED9-453A-B187-86A57C08A20AQ34993938-B400D02C-01D7-4AEB-9D3F-A7B154EF367BQ35368556-2BA827A3-20D0-4B5A-8153-C2760238DEFCQ35407336-5B484109-1D27-401F-A0D1-5C31D67379AFQ35864288-89B44A14-E309-4E12-864D-1FEF900005F5Q35931492-552186A6-057E-4358-B2B2-B5B9537B4249Q36235559-F2F68468-B4C1-4FCF-BE2B-23425DD5A8AFQ36290654-C3C73176-A9EF-4394-ACBF-7E430E82C2D5Q36303760-6E0440B3-EA85-4D4B-A4F0-7AC8574B345AQ36853113-0D658801-856D-4D2A-A570-9055936D3BBCQ37561844-19B12E31-634B-4A5A-8C16-FC51653DC82FQ37843817-6AFBB47C-4A11-47A3-9D22-55019BCB9BBEQ39678893-F3F8808F-908B-4A91-BADA-8CF6D1762F1CQ50220917-59560FD9-FEC6-4D54-98DE-EABB099C5C40Q50259927-4B45B93D-2D0D-48DC-98BB-41A9B55E05FCQ50852334-F05CE499-7290-4C37-9E6F-30203A7A2909Q52873651-387C872B-95B5-40E0-B2D5-C35B7B4BF59BQ55167704-B3CBAB07-3CE7-4FFC-994D-01C8BE4EB562Q57498713-9DB047BC-3C2D-40E5-8CCD-6480B7E46870
P2860
Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@ast
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@en
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@nl
type
label
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@ast
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@en
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@nl
prefLabel
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@ast
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@en
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@nl
P2093
P2860
P356
P1476
Kinetic curves of malignant le ...... rast-enhanced MRI acquisition.
@en
P2093
Abbie M Wood
Akiko Shimauchi
Gillian M Newstead
Gregory S Karczmar
Lindsay Zak
Sanaz A Jansen
Xiaobing Fan
P2860
P304
P356
10.2214/AJR.08.2025
P407
P577
2009-09-01T00:00:00Z